Janice J Chou

Title: Janice J Chou: Innovator in Gene Therapy

Introduction

Janice J Chou is a prominent inventor based in North Bethesda, MD (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of glycogen storage diseases. With a total of 6 patents to her name, her work has the potential to impact many lives.

Latest Patents

One of her latest patents is focused on adeno-associated virus vectors encoding modified G6PC. This invention describes modified G6PC (glucose-6-phosphatase, catalytic subunit) nucleic acids and glucose-6-phosphatase-α (G6Pase-α) enzymes that exhibit increased phosphohydrolase activity. The patent also details vectors, such as adeno-associated virus (AAV) vectors, and recombinant AAV expressing modified G6Pase-α. These AAV vectors and rAAV can be utilized for gene therapy applications in treating glycogen storage disease, particularly glycogen storage disease type Ia (GSD-Ia), and its complications.

Career Highlights

Janice has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Florida Research Foundation, Incorporated. Her experience in these institutions has allowed her to advance her research and contribute to significant innovations in her field.

Collaborations

Janice has collaborated with notable professionals, including Barry John Byrne, enhancing her research and development efforts in gene therapy.

Conclusion

Janice J Chou's innovative work in gene therapy, particularly her patents related to glycogen storage diseases, showcases her dedication to advancing medical science. Her contributions are paving the way for new treatment options and improving patient outcomes.